Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
abemaciclib (verzenio) (1 trial)
cc-115 (1 trial)
nerlynx (1 trial)
temozolomide (temodar) (1 trial)
personalized neoantigen vaccine (1 trial)
Glioblastoma (Phase 2)
Trials (2 total)
Trial APIs (5 total)